Skip to main content

22nd Century Group, Inc.

corporate_fare Company Profile

22nd Century Group, Inc.

XXII·NASDAQ·Life Sciences·CIK 0001347858

22nd Century Group, Inc. is a tobacco products company focused on allowing cigarette smokers to control their nicotine consumption. The company manufactures and distributes combustible tobacco products with minimally or non-addictive nicotine levels, which are authorized by the US Food and Drug Administration (FDA) for retail sale. They also offer contract manufacturing services for cigarettes and filtered cigars to other tobacco brands. Their primary product, the VLN® cigarette, contains 95% less nicotine than traditional cigarettes and is designed to help reduce nicotine consumption. The company aims to provide adult smokers with the option to avoid addictive levels of nicotine. In December 2021, 22nd Century Group received Modified Risk Tobacco Product (MRTP) orders from the FDA for the marketing and sale of their RNC cigarettes, marking the first and only such orders for a combusted tobacco product.

22nd Century Group, Inc. (NASDAQ:XXII) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 31 items for XXII at importance 7 or higher on its 1–10 market-impact scale.

Recent high-impact activity:

  • 22nd Century Group Registers Highly Dilutive $6.4M ATM Offering, Operationalizing Prior Authorization Amid Going Concern Doubts
  • Proxy Statement Reveals No Executive Cash Bonuses for 2025 Amid Continued Net Losses
  • 22nd Century Group Launches Highly Dilutive $1.84M ATM Offering Amid Going Concern Doubts
  • 22nd Century Group Launches Highly Dilutive $1.84M ATM Offering Amid Going Concern Doubts
  • 22nd Century Group Files $250M Universal Shelf & Amends ATM Program Amid Going Concern Doubts

Financial Snapshot

Fiscal year ended December 31, 2025
Revenue
$17.59M
Net Income
-$5.05M
Diluted EPS
-$52.87
Op. Cash Flow
-$7.72M
Free Cash Flow
-$7.78M
Gross Profit
$7.4M
Operating Income
-$11.57M
Cash & Equivalents
$7.15M
Total Debt
$708K
Debt / Equity
0.04×
Net Margin
-28.7%
Shares Outstanding
510.38K sh
Source: 10-K · filed 2026-03-26 · accession 0001104659-26-034814
$0.89 -0.02% today
52-week range · as of 2026-08-14 $0.89 – $741.48
Market cap
$652.59K
Volume
120.7K (0.6× avg)
3-mo avg 194.5K
Live data · 2026-10-05 05:59 UTC · Market overnight

show_chartPrice Chart

Loading chart...

feed XXII - Filings & News (Page 2)

XXII
May 01, 2026, 5:15 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $0.8479
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Apr 29, 2026, 4:30 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.67
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Apr 10, 2026, 4:35 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.96
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Apr 10, 2026, 4:30 PM EDT
Filing Type: 424B5
Importance Score:
9
Price at Filing: $1.96
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Mar 31, 2026, 5:00 PM EDT
Filing Type: S-3
Importance Score:
9
Price at Filing: $2.30
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Mar 26, 2026, 6:10 AM EDT
Filing Type: 10-K
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Mar 26, 2026, 6:00 AM EDT
Source: GlobeNewswire
Importance Score:
9
Price at Filing: $3.43
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Mar 24, 2026, 1:57 PM EDT
Filing Type: 424B5
Importance Score:
10
Price at Filing: $3.45
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Mar 20, 2026, 5:14 PM EDT
Filing Type: 8-K
Importance Score:
10
Price at Filing: $3.57
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Feb 20, 2026, 4:15 PM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $5.69
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
XXII
Jan 22, 2026, 8:00 AM EST
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.650
Real-time Price: $0.890 info
Change: Reverse Stock Split info
Market Cap: $652.591K info
Research tools: Filing Impact Index Dilution Tracker Split Calendar Open Datasets